MacroGenics, Inc. (MGNX)
NASDAQ: MGNX · Real-Time Price · USD
1.310
-0.060 (-4.38%)
At close: Jun 20, 2025, 4:00 PM
1.350
+0.040 (3.05%)
After-hours: Jun 20, 2025, 7:57 PM EDT
MacroGenics Employees
MacroGenics had 341 employees as of December 31, 2024. The number of employees increased by 2 or 0.59% compared to the previous year.
Employees
341
Change (1Y)
2
Growth (1Y)
0.59%
Revenue / Employee
$451,760
Profits / Employee
-$163,672
Market Cap
82.65M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
MGNX News
- 9 days ago - MacroGenics: Working On That Road To Recovery - Seeking Alpha
- 10 days ago - MacroGenics and Sagard Healthcare Partners Enter into ZYNYZ® Royalty Purchase Agreement - GlobeNewsWire
- 17 days ago - MacroGenics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025 - GlobeNewsWire
- 5 weeks ago - MacroGenics Provides Update on Corporate Progress and First Quarter 2025 Financial Results - GlobeNewsWire
- 6 weeks ago - MacroGenics Announces Date of First Quarter 2025 Financial Results - GlobeNewsWire
- 7 weeks ago - MacroGenics to Participate in Upcoming Investor Conference - GlobeNewsWire
- 3 months ago - MacroGenics, Inc. (MGNX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - MacroGenics Announces Date of Fourth Quarter and Full Year 2024 Financial Results Conference Call - GlobeNewsWire